Corticosteroids for COVID-19 symptoms and quality of life at 1 year from admission.
Ontology highlight
ABSTRACT: The long-term evolution of COVID-19 is unknown, making it necessary to study the persistence of symptoms over time and their impact on quality of life in people who have had the disease. We analyzed these aspects 1 year after admission for COVID-19 and explored the influence of treatment with systemic corticosteroids during the acute phase of the illness. This observational cohort study took place in a tertiary hospital in March and April 2021 and included people admitted due to infection with SARS-CoV-2 in March, April, or May 2020. We excluded patients who had died, were unreachable or had substantial cognitive impairment. A telephone survey was undertaken to assess the presence of symptoms related to COVID-19 and to administer the SF-36 quality of life questionnaire. Other variables col
SUBMITTER: Catalan IP
PROVIDER: S-EPMC8662039 | biostudies-literature | 2022 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA